Clinical Trial Update: Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating angiotensin receptor blockers for COVID-19 outcomes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Snippet

Sponsor: The George Institute | Conditions: Coronavirus Disease 2019, COVID-19 | Phase 4 | Status: COMPLETED